"Newer generations of hormonal contraceptives may reduce cardiovascular risks compared with early high-dose formulations, researchers said. Third-generation oral contraceptives carry lower androgenic and metabolic side effects, no MI risk, and reduced venous thromboembolism risk compared with earlier generations, according to a review in the January 20 issue of the Journal of the American College of Cardiology" - medpageToday
No comments:
Post a Comment